SCHEMBL22031182

SCHEMBL22031182

C=C(C(CC)N(C)C(C)(C)C)N(C)C(CCCCN)C(=C)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23220203 0.84 — —
SCHEMBL18824011 0.76 SIRT6 (0.30) —
SCHEMBL18594710 0.72 CA2 (0.31) —
SCHEMBL19483440 0.71 CPB2 (0.38) —
SCHEMBL20992224 0.68 — —
SCHEMBL23805338 0.66 — —
SCHEMBL23801160 0.65 — —
SCHEMBL24943948 0.65 GSR (0.47) —
SCHEMBL19647402 0.65 CPB2 (0.33) —
SCHEMBL18823998 0.64 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200164084-A1 ANTIBODY CONJUGATES COMPRISING TOLL-LIKE RECEPTOR AGONIST AND COMBINATION THERAPIES NOVARTIS AG (CH) 2020-05-28 — — US disclosed
Send feedback